References

Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial

10.1001/jama.2011.991 · ExternalCitation · doi-reference

Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease

10.1002/14651858.cd012847 · ExternalCitation · doi-reference

Childbearing and survival after breast carcinoma in young women

10.1002/cncr.11634 · ExternalCitation · doi-reference

Gender disparity in the rate of partner abandonment in patients with serious medical illness

10.1002/cncr.24577 · ExternalCitation · doi-reference

Birth outcomes among offspring of adult cancer survivors: a population-based study

10.1002/ijc.28292 · ExternalCitation · doi-reference

The risk of preterm birth and growth restriction in pregnancy after cancer

10.1002/ijc.30914 · ExternalCitation · doi-reference

ESGO/ESTRO/ESP guidelines for the management of patients with cervical cancer – update 2023

10.1007/s00428-023-03552-3 · ExternalCitation · doi-reference

Fertility preservation in women of reproductive age with cancer

10.1016/j.ajog.2012.08.013 · ExternalCitation · doi-reference

Neo-adjuvant chemotherapy in fertility-sparing cervical cancer treatment

10.1016/j.bpobgyn.2021.01.010 · ExternalCitation · doi-reference

Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: systematic review and meta-analysis of randomized trials

10.1016/j.ctrv.2013.12.001 · ExternalCitation · doi-reference

Assessing risks and knowledge gaps on the impact of systemic therapies in early breast cancer on female fertility: a systematic review of the literature

10.1016/j.ctrv.2024.102769 · ExternalCitation · doi-reference

Fertility and reproductive concerns related to the new generation of cancer drugs and the clinical implication for young individuals undergoing treatments for solid tumors

10.1016/j.ejca.2024.114010 · ExternalCitation · doi-reference

Reproductive, obstetrical and oncological outcomes of fertility-sparing treatment for cervical cancer according to the FIGO 2018 staging system: a systematic review

10.1016/j.ejso.2024.109359 · ExternalCitation · doi-reference

Safety of pregnancy after breast cancer in young women with hormone receptor-positive disease: a systematic review and meta-analysis

10.1016/j.esmoop.2023.102031 · ExternalCitation · doi-reference

Safety of having a subsequent pregnancy after prior diagnosis of breast cancer during pregnancy in young BRCA carriers

10.1016/j.esmoop.2025.105513 · ExternalCitation · doi-reference

Reproductive and oncologic outcomes after fertility-sparing surgery for early stage cervical cancer: a systematic review

10.1016/j.fertnstert.2020.02.003 · ExternalCitation · doi-reference

Fertility preservation in patients with medical indications: a committee opinion

10.1016/j.fertnstert.2025.12.001 · ExternalCitation · doi-reference

Fertility preservation and reproduction in patients facing gonadotoxic therapies or gonadectomy: an ethics committee opinion

10.1016/j.fertnstert.2025.12.002 · ExternalCitation · doi-reference

Predicting age of ovarian failure after radiation to a field that includes the ovaries

10.1016/j.ijrobp.2004.11.038 · ExternalCitation · doi-reference

Post-conization cervical stenosis treated with silicone catheter in microinvasive cervical cancer patient: a case report

10.1016/j.ijscr.2020.02.005 · ExternalCitation · doi-reference

Patient–physician communication barriers regarding fertility preservation among newly diagnosed cancer patients

10.1016/j.socscimed.2007.09.013 · ExternalCitation · doi-reference

ESGO–ESTRO–ESP guidelines for the management of patients with endometrial carcinoma: update 2025

10.1016/s1470-2045(25)00167-6 · ExternalCitation · doi-reference

Interrupting endocrine therapy to attempt pregnancy after breast cancer

10.1056/nejmoa2212856 · ExternalCitation · doi-reference

Fertility-sparing surgery in epithelial ovarian cancer: a systematic review of oncological issues

10.1093/annonc/mdw311 · ExternalCitation · doi-reference

GnRH agonist for protection against ovarian toxicity during chemotherapy for early breast cancer: the Anglo Celtic Group OPTION trial

10.1093/annonc/mdx184 · ExternalCitation · doi-reference

Pregnancy outcomes in childhood cancer survivors according to uterine radiation dose and other factors

10.1093/bjr/tqaf130 · ExternalCitation · doi-reference

ESHRE guideline: female fertility preservation

10.1093/hropen/hoaa052 · ExternalCitation · doi-reference

Gonadotoxicity of immunotherapy and targeted agents in patients with cancer and impact on subsequent pregnancies

10.1093/humrep/deaf096 · ExternalCitation · doi-reference

The radiosensitivity of the human oocyte

10.1093/humrep/deg016 · ExternalCitation · doi-reference

Long-term safety of pregnancy following breast cancer according to estrogen receptor status

10.1093/jnci/djx206 · ExternalCitation · doi-reference

Unraveling the mechanisms of chemotherapy-induced damage to human primordial follicle reserve: road to developing therapeutics for fertility preservation and reversing ovarian aging

10.1093/molehr/gaaa043 · ExternalCitation · doi-reference

Adverse pregnancy outcomes after treatment for cervical intraepithelial neoplasia

10.1097/aog.0000000000001777 · ExternalCitation · doi-reference

Outcomes of the first pregnancy after fertility-sparing surgery for early-stage ovarian cancer

10.1097/aog.0000000000004394 · ExternalCitation · doi-reference

Pregnancy outcomes after fertility-sparing management in young women with early endometrial cancer

10.1097/aog.0b013e31827a0643 · ExternalCitation · doi-reference

Gonadotropin-releasing hormone agonists for ovarian protection during breast cancer chemotherapy: a systematic review and meta-analysis

10.1097/gme.0000000000002019 · ExternalCitation · doi-reference

Association between reproductive cancer and fetal outcomes: a population-based study

10.1097/igc.0b013e31827b877b · ExternalCitation · doi-reference

Fertility-sparing surgery of cervical cancer >2 cm (International Federation of Gynecology and Obstetrics 2009 stage IB1-IIA) after neoadjuvant chemotherapy

10.1136/ijgc-2019-000647 · ExternalCitation · doi-reference

Oncological and obstetrical outcomes after neo-adjuvant chemotherapy followed by fertility-sparing surgery in patients with cervical cancer ≥2 cm

10.1136/ijgc-2020-002076 · ExternalCitation · doi-reference

ESGO/ESHRE/ESGE guidelines for the fertility-sparing treatment of patients with endometrial carcinoma

10.1136/ijgc-2022-004047 · ExternalCitation · doi-reference

Evaluation of parametrial status in locally advanced cervical cancer patients after neoadjuvant chemotherapy: a prospective study on diagnostic accuracy of three-dimensional transvaginal ultrasound

10.1159/000506642 · ExternalCitation · doi-reference

Fertility preservation in people with cancer: ASCO guideline update

10.1200/jco-24-02782 · ExternalCitation · doi-reference

Drug-induced DNA damage and tumor chemosensitivity

10.1200/jco.1990.8.12.2062 · ExternalCitation · doi-reference

Incidence, time course, and determinants of menstrual bleeding after breast cancer treatment: a prospective study

10.1200/jco.2005.03.3969 · ExternalCitation · doi-reference

Gonadotropin-releasing hormone agonist for the prevention of chemotherapy-induced ovarian failure in patients with lymphoma: 1-year follow-up of a prospective randomized trial

10.1200/jco.2012.42.8185 · ExternalCitation · doi-reference

No evidence for the benefit of gonadotropin-releasing hormone agonist in preserving ovarian function and fertility in lymphoma survivors treated with chemotherapy: final long-term report of a prospective randomized trial

10.1200/jco.2015.65.8864 · ExternalCitation · doi-reference

Gonadotropin-releasing hormone agonists during chemotherapy for preservation of ovarian function and fertility in premenopausal patients with early breast cancer: a systematic review and meta-analysis of individual patient-level data

10.1200/jco.2018.78.0858 · ExternalCitation · doi-reference

Relationship between cervical excisional treatment for cervical intraepithelial neoplasia and obstetrical outcome

10.23736/s2724-606x.20.04678-x · ExternalCitation · doi-reference

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

10.3322/caac.21660 · ExternalCitation · doi-reference

Hysteroscopic surgery for conservative management in endometrial cancer: a review of the literature

10.3332/ecancer.2015.505 · ExternalCitation · doi-reference

Development of a nomogram predicting the risk of persistence/recurrence of cervical dysplasia

10.3390/vaccines10040579 · ExternalCitation · doi-reference

Hysteroscopy in fertility-sparing management for early endometrial cancer: a double-edged sword

10.3802/jgo.2017.28.e16 · ExternalCitation · doi-reference

Fertility-sparing surgery for women with stage I cervical cancer of 4 cm or larger: a systematic review

10.3802/jgo.2021.32.e83 · ExternalCitation · doi-reference

Fertility preservation in female cancer patients: an overview

10.4103/0974-1208.153119 · ExternalCitation · doi-reference

Fertility-sparing treatment in early endometrial cancer: current state and future strategies

10.5468/ogs.19169 · ExternalCitation · doi-reference